Literature DB >> 8218048

Choroidal invasion of retinoblastoma: metastatic potential and clinical risk factors.

C L Shields1, J A Shields, K A Baez, J Cater, P V De Potter.   

Abstract

There is considerable debate about the significance of choroidal invasion of retinoblastoma with regard to metastatic disease. The charts of patients with retinoblastoma were reviewed over a 17 year period to determine the frequency of histopathological choroidal invasion of retinoblastoma and its risk for eventual metastatic disease. Sixty seven of 289 eyes (23%) enucleated for retinoblastoma had histopathological evidence of choroidal invasion. Those patients with choroidal invasion (with or without optic nerve invasion) were more likely to develop metastases than those without choroidal invasion (p = 0.0001). When considering those patients with isolated choroidal invasion of retinoblastoma, excluding those with associated optic nerve invasion, there was no significant risk but there was a trend towards the development of metastases (p = 0.10). The clinical factors found to be predictive for choroidal invasion from retinoblastoma from a univariate analysis included increased intraocular pressure (p = 0.04) and iris neovascularisation (p = 0.007) and, from a multivariate analysis, iris neovascularisation (p = 0.02). The histopathological factors statistically associated with choroidal invasion included the presence of optic nerve invasion (p = 0.002) and poorly differentiated retinoblastoma (p = 0.003). Factors not predictive for choroidal invasion included the age, race, and sex of the patient and the tumour laterality, inheritance, size, and growth pattern. Choroidal invasion of retinoblastoma is a risk for metastases, especially if it is associated with any degree of optic nerve invasion.

Entities:  

Mesh:

Year:  1993        PMID: 8218048      PMCID: PMC513947          DOI: 10.1136/bjo.77.9.544

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  19 in total

1.  The Registry of Ophthalmic Pathology: past, present and future.

Authors:  L E ZIMMERMAN
Journal:  Trans Am Acad Ophthalmol Otolaryngol       Date:  1961 Jan-Feb

2.  A study of retinoblastoma.

Authors:  R J HERM; P HEATH
Journal:  Am J Ophthalmol       Date:  1956-01       Impact factor: 5.258

3.  Prognosis and treatment of retinoblastoma. 105 cases treated at Institut Curie.

Authors:  C Haye; L Desjardins; C Elmaleh; P Schlienger; J M Zucker; M Laurent
Journal:  Ophthalmic Paediatr Genet       Date:  1989-09

4.  Pseudo-Schnabel's cavernous degeneration of the optic nerve secondary to intraocular silicone oil.

Authors:  C L Shields; R C Eagle
Journal:  Arch Ophthalmol       Date:  1989-05

5.  Optic nerve involvement in retinoblastoma.

Authors:  I Magramm; D H Abramson; R M Ellsworth
Journal:  Ophthalmology       Date:  1989-02       Impact factor: 12.079

6.  Prognostic importance of choroidal invasion in retinoblastoma.

Authors:  L D Redler; R M Ellsworth
Journal:  Arch Ophthalmol       Date:  1973-10

Review 7.  Retinoblastoma: clinical and histopathologic features.

Authors:  D N Sang; D M Albert
Journal:  Hum Pathol       Date:  1982-02       Impact factor: 3.466

8.  Prevalence and mechanisms of secondary intraocular pressure elevation in eyes with intraocular tumors.

Authors:  C L Shields; J A Shields; M B Shields; J J Augsburger
Journal:  Ophthalmology       Date:  1987-07       Impact factor: 12.079

9.  Multivariate analysis of risk factors for metastasis in retinoblastoma treated by enucleation.

Authors:  J E Kopelman; I W McLean; S H Rosenberg
Journal:  Ophthalmology       Date:  1987-04       Impact factor: 12.079

10.  Invasion of the optic nerve by retinoblastoma: a clinicopathological study.

Authors:  J Rootman; J Hofbauer; R M Ellsworth; D Kitchen
Journal:  Can J Ophthalmol       Date:  1976-04       Impact factor: 1.882

View more
  38 in total

1.  Retinoblastoma - MR appearance using a surface coil in comparison with histopathological results.

Authors:  Arne-Jörn Lemke; Iris Kazi; Ulrike Mergner; Paul Ivan Foerster; Heinrich Heimann; Nikolaos Bechrakis; Andreas Schüler; Marie-Isabell Senfft von Pilsach; Michael Foerster; Roland Felix; Norbert Hosten
Journal:  Eur Radiol       Date:  2006-04-25       Impact factor: 5.315

Review 2.  Chemotherapy for retinoblastoma: a current topic.

Authors:  P T Finger; G Czechonska; H Demirci; A Rausen
Journal:  Drugs       Date:  1999-12       Impact factor: 9.546

3.  Retinoblastoma. Fifty years of progress. The LXXI Edward Jackson Memorial Lecture.

Authors:  Hans E Grossniklaus
Journal:  Am J Ophthalmol       Date:  2014-07-24       Impact factor: 5.258

4.  High-resolution MRI using orbit surface coils for the evaluation of metastatic risk factors in 143 children with retinoblastoma: Part 1: MRI vs. histopathology.

Authors:  Selma Sirin; Marc Schlamann; Klaus A Metz; Norbert Bornfeld; Bernd Schweiger; Markus Holdt; Petra Temming; Michael M Schuendeln; Sophia L Goericke
Journal:  Neuroradiology       Date:  2015-06-04       Impact factor: 2.804

5.  Distinct Gene Expression Profiles Define Anaplastic Grade in Retinoblastoma.

Authors:  Lauren E Hudson; Pia Mendoza; William H Hudson; Alison Ziesel; G Baker Hubbard; Jill Wells; Bhakti Dwivedi; Jeanne Kowalski; Sandra Seby; Viren Patel; Eldon Geisert; Charles Specht; Hans E Grossniklaus
Journal:  Am J Pathol       Date:  2018-07-21       Impact factor: 4.307

6.  High-risk histomorphological features in retinoblastoma and their association with p53 expression: An Indian experience.

Authors:  Rao Seema; Sobti Parul; Khurana Nita
Journal:  Indian J Ophthalmol       Date:  2014-11       Impact factor: 1.848

7.  Retinoblastoma patients with high risk ocular pathological features: who needs adjuvant therapy?

Authors:  G L Chantada; I J Dunkel; M T G de Dávila; D H Abramson
Journal:  Br J Ophthalmol       Date:  2004-08       Impact factor: 4.638

8.  [Morphologic classification of choroidal invasion of retinoblastoma].

Authors:  H Yang; H Schilling; R Effert; A Wessing
Journal:  J Tongji Med Univ       Date:  1999

9.  Impact of tumor-associated macrophages in LH(BETA)T(AG) mice on retinal tumor progression: relation to macrophage subtype.

Authors:  Yolanda Piña; Hinda Boutrid; Timothy G Murray; Martine J Jager; Colleen M Cebulla; Amy Schefler; Long V Ly; Armando Alegret; Magda Celdran; William Feuer; Maria-Elena Jockovich
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-01-06       Impact factor: 4.799

10.  Irresponsiveness of two retinoblastoma cases to conservative therapy correlates with up- regulation of hERG1 channels and of the VEGF-A pathway.

Authors:  Pina Fortunato; Serena Pillozzi; Angela Tamburini; Liliana Pollazzi; Alessandro Franchi; Agostino La Torre; Annarosa Arcangeli
Journal:  BMC Cancer       Date:  2010-09-22       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.